Form 4 for GNLX GENELUX Corp
Accepted 2025-05-13 00:00:00 ET · period of report 2025-05-12 · accession 0001415889-25-012806 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-13 | 2025-05-12 | GNLX | Cappello Joseph | VP, Pharmaceutical Development | S - Sale | $2.92 | -4,737 | 52.3K | -8% | -$13.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-12 | S | D | 4,737 | $2.92 | 52,266 | D | — | — |